Authors


Kaylee N. Meador, BS

Latest:

Two Laws Expand Protections for Nursing Employees

Creating additional space for nursing mothers can be challenging in small pharmacies


Ashlan J. Kunz Coyne, PharmD, MPH

Latest:

RSV Vaccines See a Pricey Leap Forward in Disease Prevention

Older adults without a Part D plan face costs ranging from $180 to $295 per shot.



Zakieh Abuelkhair, RPH, MPBA Candidate

Latest:

Establishing Specialty Pharmacy Beyond US Borders: Opportunities and Challenges

The 5 largest specialty therapeutic groups—oncology, autoimmune, immunology, HIV, and multiple sclerosis—will account for 74% of specialty spending growth over the next five years.


Nisha Venugopal, PhD

Latest:

Affordability of Orphan Drugs Hinges on Global Collaboration

Cross-border collaborations are the way forward to make life-saving treatments more affordable and accessible to patients with rare diseases around the world.


Padma Rammoorthy, MD

Latest:

Global Patient Registries Can Advance Opportunities for Rare Disease Research

Collaboration and knowledge sharing amongst rare disease researchers can be difficult, as these researchers are often spread out throughout the world.



Christine Hong, PharmD Candidate

Latest:

Optimizing Self-Management for Outpatient Pharmacy Patients With Diabetes

The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.


Angela Chau, PharmD

Latest:

The Role of Physical Activity in Breast Cancer Risk Reduction and Survival

Pharmacists can educate patients on nonpharmacologic strategies that help improve survival outcomes.


Elizabeth A. Hansen, PharmD, BCOP

Latest:

New Therapeutics Treat Homologous Recombination Repair Deficiency

Understanding causes, consequences proves vital to develop therapies that exploit vulnerabilities of the cancer cells.



Raechel Lozano, PharmD, BCACP

Latest:

Wearable Wrist Monitoring Devices Can Improve Atrial Fibrillation Outcomes

The use of devices like Apple watches may offer a more affordable and less burdensome modality to diagnose atrial fibrillation.



Nakia Eldridge, PharmD, MBA

Latest:

APhA 2025: Nakia Eldridge, PharmD, MBA, Highlights Must-See Sessions

Nakia Eldridge, PharmD, MBA, shares insights for health system and community pharmacists attending the 2025 APhA Annual Meeting & Exposition.


Madison Savidge, PharmD, MBA

Latest:

Equitable Representation in Triple-Negative Breast Cancer Clinical Trials

Black women have higher rates of triple-negative breast cancer (TNBC) incidence and mortality than the general US population. Despite this, they are underrepresented in TNBC clinical trials.


Nancy Mendelsohn, MD

Latest:

A New Frontier in the Fight Against Rare Disease

Rare disease specialty pharmacies offer customizable pharmacy and patient services to make it easier for people living with rare, complex, and often isolating conditions to access the therapy, care, and resources they need.


Trisha A. Miller, PharmD, MPh, BCACP

Latest:

Developing and Implementing Immunization Standing Orders and Protocols

Vaccine administration provides benefits at the patient and public health levels, and pharmacists are critical members of health care teams that provide these vital biologic medications.


Nandini Ramsumair PharmD, BS Pharm

Latest:

Actionable Mutations in Hematologic Malignancies

The use of high throughput technologies has revolutionized the understanding of the cancer genome.


Ruben Zorrilla, PharmD Candidate

Latest:

Fourth-Year Pharmacy Students Help Patients and Practitioners in Transitional Care

Students are being exposed to new patient experiences through collaboration with practitioners.


Ben May, PharmD, CSP

Latest:

Focus on Multiple Sclerosis: Benefits of Advanced Pharmacist Certification, a Glimpse into the Drug Pipeline

Pharmacists who educate patients with multiple sclerosis and expand their understanding and knowledge of the condition empowers them to take part in a more active role in managing their health.


Mitch Rotholz, PharmD

Latest:

Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health Outcomes

Additional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.


Breanna Taylor, PharmD, BCOP

Latest:

Updates in the Management of Transplant-Ineligible Patients With Multiple Myeloma

Explore the latest advancements in treating transplant-ineligible multiple myeloma, highlighting new therapies and clinical trial outcomes for improved patient care.


Jason Christidhis, PharmD Candidate 2024

Latest:

Summer Skincare: Sunburn and Allergic Contact Dermatitis

Patients may consult with their pharmacist regarding appropriate protection methods and treatment options available for common summer skin ailments.


Christina Bookwalter, PharmD, MS MEd, BCPS, BCACP

Latest:

The Evolution of Biologics and Biosimilars: Reducing Costs and Improving Accessibility Through Pharmacist Engagement

Original biologic products, and more recently biosimilar products, are a groundbreaking advancement in modern medical treatments. Pharmacists should understand biologic products and concerns with biosimilars.


Jenna Januszka, PharmD, BCPS, AAHIVP

Latest:

The Art of ART: The Pharmacist’s Role in HIV Care

Pharmacists involvement in HIV care and treatment has been shown to lead to clinically and statistically significant improvements in ART adherence, as well as greater viral load suppression for patients with HIV.


Rose McNulty

Latest:

Differentiating Features of Atypical Hepatocellular Carcinoma vs Intrahepatic Mass-Forming Cholangiocarcinoma in Contrast-Enhanced MRI

Distinguishing between atypical hepatocellular carcinomas and intrahepatic cholangiocarcinoma can be difficult, but researchers identified several reliable MRI features to assist in differentiation.


Christian Ruff, MD, MPH

Latest:

New Data Highlights Abelacimab’s Safety Advantage in Atrial Fibrillation

Christian Ruff, MD, highlights abelacimab’s potential to significantly reduce bleeding in patients with high-risk atrial fibrillation.


David Filstein

Latest:

Outlook for Health System-Based Specialty Pharmacy in 2022 and Beyond

With integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.


Mark N. Sorial, PharmD, BCOP

Latest:

Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical Considerations

This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.


Hasina Jalala

Latest:

When It Comes to Curbing Drug Abuse, Technicians Are Crucial

Adequate training will help them recognize signs of misuse and assist with preventive measures.